Saturday, 21 September 2019

Orodispersible technology

14 March 2012 | News | By Nandita Singh

The orodispersible tablet (ODT) technology offers advantages over the traditional dosage formulations as they allow easy swallowing without the use of water in paediatrics and geriatrics patient populations.

This technology is advantageous to patients suffering from diseases, such as mouth cancer, where swallowing the drug is a challenge. Global drug giant Merck has launched ODT technologies for delivery of water-insoluble compounds with robust in-vivo performance.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Podcast

 

Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls